Related references
Note: Only part of the references are listed.Heart Disease and Stroke Statistics-2014 Update A Report From the American Heart Association
Alan S. Go et al.
CIRCULATION (2014)
Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration
Fabio R. Formiga et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Tunable Protein Release from Acetalated Dextran Microparticles: A Platform for Delivery of Protein Therapeutics to the Heart Post-MI
Sophia Suarez et al.
BIOMACROMOLECULES (2013)
Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction
Inthirai Somasuntharam et al.
BIOMATERIALS (2013)
Induction of Angiogenesis by Controlled Delivery of Vascular Endothelial Growth Factor Using Nanoparticles
Jiaqi Xie et al.
CARDIOVASCULAR THERAPEUTICS (2013)
Passive targeting of lipid-based nanoparticles to mouse cardiac ischemia-reperfusion injury
Tessa Geelen et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2013)
Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success
Galina Dragneva et al.
DISEASE MODELS & MECHANISMS (2013)
Biodegradation and heart retention of polymeric micropaiticles in a rat model of myocardial ischemia
F. R. Formiga et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction
Todd D. Johnson et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Functional benefits of PLGA particulates carrying VEGF and CoQ10 in an animal of myocardial ischemia
Teresa Simon-Yarza et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Effects of platelet-rich plasma-containing fragmin/protamine microparticles in enhancing endothelial and smooth muscle cell growth and inducing collateral vessels in a rabbit model of hindlimb ischemia
Masanori Fujita et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2013)
Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction
Ming-Yao Chang et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis
Seung-Hwa Shin et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Heart Disease and Stroke Statistics-2012 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2012)
Therapeutic Angiogenesis of PLGA-Heparin Nanoparticle in Mouse Ischemic Limb
Lishan Lian et al.
JOURNAL OF NANOMATERIALS (2012)
Enhancement of Cell-Based Therapeutic Angiogenesis Using a Novel Type of Injectable Scaffolds of Hydroxyapatite-Polymer Nanocomposite Microspheres
Yohei Mima et al.
PLOS ONE (2012)
Attenuation of Limb Loss in an Experimentally Induced Hindlimb Ischemic Model by Fibroblast Growth Factor-2/Fragmin/Protamine Microparticles as a Delivery System
Shingo Nakamura et al.
TISSUE ENGINEERING PART A (2012)
The enhancement of endothelial cell therapy for angiogenesis in hindlimb ischemia using hyaluronan
Zack C. W. Tang et al.
BIOMATERIALS (2011)
A nanobiohybrid complex of recombinant baculovirus and Tat/DNA nanoparticles for delivery of Ang-1 transgene in myocardial infarction therapy
Arghya Paul et al.
BIOMATERIALS (2011)
Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure
Antonio Cittadini et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Treatment of Leg Ischemia With Biodegradable Gelatin Hydrogel Microspheres Incorporating Granulocyte Colony-stimulating Factor
Itta Kawamura et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Targeted Delivery of Nanoparticles to Ischemic Muscle for Imaging and Therapeutic Angiogenesis
Jaeyun Kim et al.
NANO LETTERS (2011)
Nanoparticles Targeting the Infarcted Heart
Tal Dvir et al.
NANO LETTERS (2011)
Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair
Tamar Harel-Adar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
N-acetylglucosamine Conjugated to Nanoparticles Enhances Myocyte Uptake and Improves Delivery of a Small Molecule p38 Inhibitor for Post-infarct Healing
Warren D. Gray et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2011)
The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury
Gokulakrishnan Seshadri et al.
BIOMATERIALS (2010)
Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice
Xun Qi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model
Fabio R. Formiga et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Sustained Release of Multiple Growth Factors from Injectable Polymeric System as a Novel Therapeutic Approach Towards Angiogenesis
Qinghua Sun et al.
PHARMACEUTICAL RESEARCH (2010)
Stem cell and progenitor cell therapy in peripheral artery disease A critical appraisal
Holger Lawall et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Controlled Release of Matrix Metalloproteinase-1 Plasmid DNA Prevents Left Ventricular Remodeling in Chronic Myocardial Infarction of Rats
Xue Lin et al.
CIRCULATION JOURNAL (2009)
Local Sustained Release of Prostaglandin E1 Induces Neovascularization in Murine Hindlimb Ischemia
Jiro Esaki et al.
CIRCULATION JOURNAL (2009)
Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function
Robert C. Scott et al.
FASEB JOURNAL (2009)
Retention and biodistribution of microspheres injected into ischemic myocardium
Jeff N. Anderl et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2009)
Sustained release of prostaglandin E1 potentiates the impaired therapeutic angiogenesis by basic fibroblast growth factor in diabetic murine Hindlimb ischemia
Yuhong Huang et al.
CIRCULATION JOURNAL (2008)
Vascular permeability in cardiovascular disease and cancer
Sara M. Weis
CURRENT OPINION IN HEMATOLOGY (2008)
Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model
Robert F. Foronjy et al.
HYPERTENSION RESEARCH (2008)
Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction
Jay C. Sy et al.
NATURE MATERIALS (2008)
Targeted Delivery of Nanoparticles Bearing Fibroblast Growth Factor-2 by Ultrasonic Microbubble Destruction for Therapeutic Arteriogenesis
John C. Chappell et al.
SMALL (2008)
Protective effect of coenzyme Q10-loaded liposomes on the myocardium in rabbits with an acute experimental myocardial infarction
Daya D. Verma et al.
PHARMACEUTICAL RESEARCH (2007)
Effective uptake of N-acetylglucosamine-conjugated liposomes by cardiomyocytes in vitro
Shin-ichi Aso et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel - An initial report of the phase I-IIa study
Akira Marui et al.
CIRCULATION JOURNAL (2007)
Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rgl, for intramyocardial injection in a rat model with infarcted myocardium
Hao-Ji Wei et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Matrix metalloproteinases and myocardial infarction
Wannakorn Phatharajaree et al.
CANADIAN JOURNAL OF CARDIOLOGY (2007)
Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction
Robert C. Scott et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Combined treatment with sustained-release basic fibroblast growth factor and heparin enhances neovascularization in hypercholesterolemic mouse hindlimb ischemia
Yoshio Arai et al.
CIRCULATION JOURNAL (2007)
Growth factors for therapeutic angiogenesis in peripheral arterial disease
William S. Jones et al.
CURRENT OPINION IN CARDIOLOGY (2007)
FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction
Felix B. Engel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: Implications for cellular cardiomyoplasty
Carolyn J. Teng et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2006)
Combined treatment of sustained-release basic fibroblast growth factor and sarpogrelate enhances collateral blood flow effectively in rabbit hindlimb ischemia
Keiichi Hirose et al.
CIRCULATION JOURNAL (2006)
Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres
K. Hoshino et al.
GENE THERAPY (2006)
Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging
Ying Liu et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2006)
Medical treatment of peripheral arterial disease
GJ Hankey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction
DD Verma et al.
PHARMACEUTICAL RESEARCH (2005)
Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy
D Watanabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: Myocardial and tissue distribution
RJ Laham et al.
DRUG METABOLISM AND DISPOSITION (2005)
P38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes
FB Engel et al.
GENES & DEVELOPMENT (2005)
Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor
H Makino et al.
HYPERTENSION RESEARCH (2004)
Type I collagen can function as a reservoir of basic fibroblast growth factor
A Kanematsu et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Fibroblast growth factor-1 improves cardiac functional recovery and enhances cell survival after ischemia and reperfusion - A fibroblast growth factor receptor, protein kinase C, and tyrosine kinase-dependent mechanism
M Palmen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1β/erbB4 signaling
Y Kuramochi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats
L Wang et al.
STROKE (2004)
Toward surgical angiogenesis using slow-released basic fibroblast growth factor
Y Sakakibara et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2003)
Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia -: Phase II results of the Kuopio Angiogenesis Trial (KAT)
M Hedman et al.
CIRCULATION (2003)
Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model
A Iwakura et al.
HEART AND VESSELS (2003)
Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease
R Khurana et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2003)
Vascular endothelial growth factor in ischemia for vascular angiogenesis
TD Henry et al.
CIRCULATION (2003)
Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs
M Onimaru et al.
CIRCULATION RESEARCH (2002)
Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2 - Double-blind, randomized, controlled clinical trial
M Simons et al.
CIRCULATION (2002)
Incomplete retention after direct myocardial injection
PM Grossman et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2002)
Peripheral arterial disease detection, awareness, and treatment in primary care
AT Hirsch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards
SE Epstein et al.
CARDIOVASCULAR RESEARCH (2001)
Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open-label dose escalation study
RJ Laham et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Clinical trials in coronary angiogenesis: Issues, problems, consensus - An expert panel summary
M Simons et al.
CIRCULATION (2000)
Infarct scar: a dynamic tissue
Y Sun et al.
CARDIOVASCULAR RESEARCH (2000)
Heparin and angiogenic therapy
M Fujita
EUROPEAN HEART JOURNAL (2000)